83 related articles for article (PubMed ID: 6538883)
1. Sensitive high-performance liquid chromatographic assay for platinum in plasma ultrafiltrate.
Reece PA; McCall JT; Powis G; Richardson RL
J Chromatogr; 1984 Mar; 306():417-23. PubMed ID: 6538883
[No Abstract] [Full Text] [Related]
2. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.
Andrews PA; Wung WE; Howell SB
Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method.
Drummer OH; Proudfoot A; Howes L; Louis WJ
Clin Chim Acta; 1984 Jan; 136(1):65-74. PubMed ID: 6319051
[TBL] [Abstract][Full Text] [Related]
4. Determination of platinum in serum and ultrafiltrate by flameless atomic absorption spectrophotometry.
Hull DA; Muhammad N; Lanese JG; Reich SD; Finkelstein TT; Fandrich S
J Pharm Sci; 1981 May; 70(5):500-2. PubMed ID: 7241351
[TBL] [Abstract][Full Text] [Related]
5. Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.
DeGregorio MW; King OY; Holleran WM; Wilbur BJ; Cadman EC; Deisseroth AB; Wilbur JR
Cancer Treat Rep; 1985 Dec; 69(12):1441-2. PubMed ID: 4075318
[TBL] [Abstract][Full Text] [Related]
6. Determination of platinum and palladium in blood and urine by flameless atomic absorption spectrophotometry.
Jones AH
Anal Chem; 1976 Sep; 48(11):1472-4. PubMed ID: 962142
[No Abstract] [Full Text] [Related]
7. A model for ultrafilterable plasma platinum disposition in patients treated with cisplatin.
Reece PA; Stafford I; Russell J; Khan M; Gill PG
Cancer Chemother Pharmacol; 1987; 20(1):26-32. PubMed ID: 3621450
[TBL] [Abstract][Full Text] [Related]
8. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.
Hanada K; Nagai N; Ogata H
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):181-6. PubMed ID: 7704209
[TBL] [Abstract][Full Text] [Related]
10. Determination of platinum, palladium, and lead in biological samples by atomic absorption spectrophotometry.
Tillery JB; Johnson DE
Environ Health Perspect; 1975 Dec; 12():19-26. PubMed ID: 1227857
[TBL] [Abstract][Full Text] [Related]
11. Determination of cisplatin and related platinum complexes in plasma ultrafiltrate and urine by high-performance liquid chromatography with on-line radioactivity detection.
Baldew GS; Volkers KJ; De Goeij JJ; Vermeulen NP
J Chromatogr; 1989 Jun; 491(1):163-74. PubMed ID: 2793971
[TBL] [Abstract][Full Text] [Related]
12. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
[TBL] [Abstract][Full Text] [Related]
13. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
14. Rapid determination of platinum by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients.
el-Yazigi A; Al-Saleh I
Ther Drug Monit; 1986; 8(3):318-20. PubMed ID: 3750375
[TBL] [Abstract][Full Text] [Related]
15. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
[TBL] [Abstract][Full Text] [Related]
16. Determination of platinum in urine, ultrafiltrate, and whole plasma by isotope dilution gas chromatography-mass spectrometry compared to electrothermal atomic absorption spectrometry.
Aggarwal SK; Gemma NW; Kinter M; Nicholson J; Shipe JR; Herold DA
Anal Biochem; 1993 Apr; 210(1):113-8. PubMed ID: 8489005
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).
Vermorken JB; van der Vijgh WJ; Pinedo HM
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316
[TBL] [Abstract][Full Text] [Related]
18. Chemical reactivity of cisplatin bound to human plasma proteins.
Hegedüs L; van der Vijgh WJ; Klein I; Kerpel-Fronius S; Pinedo HM
Cancer Chemother Pharmacol; 1987; 20(3):211-2. PubMed ID: 2824080
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations.
Ma J; Stoter G; Verweij J; Schellens JH
Cancer Chemother Pharmacol; 1996; 38(4):391-4. PubMed ID: 8674165
[TBL] [Abstract][Full Text] [Related]
20. Post-column reaction detector for platinum(II) antineoplastic agents.
Marsh KC; Sternson LA; Repta AJ
Anal Chem; 1984 Mar; 56(3):491-7. PubMed ID: 6538767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
